Commercialization Plan. The Commercialization Plan with respect to a Licensed Product shall contain in reasonable detail the major Commercialization activities, including revenue targets, planned for such Licensed Product in the Territory and estimated timelines for achieving such activities. Attached hereto as Exhibit E is an initial draft of the Commercialization Plan for the use of the Licensed Product in treating recurrent and newly diagnosed GBM. From time to time Zai shall propose updates or amendments to the Commercialization Plan and Zai shall submit the proposed updated or amended Commercialization Plan to the JSC for review, discussion, and approval before adopting such update or amendment.

Commercialization Plan. Everest shall conduct all Commercialization of Compounds and Licensed Products in the Licensed Field in the Territory in accordance with a comprehensive commercialization plan (as amended from time to time in accordance with this Agreement, the “Commercialization Plan”), the initial version of which Everest will prepare and provide to the JDC no later than ​ prior to the anticipated First Commercial Sale of Licensed Product in the Licensed Field in the Territory and which initial Commercialization Plan shall be subject to the review (but not approval) of the Parties through the JDC. From time to time, but at least once every Calendar Year, Everest will update the Commercialization Plan and submit such updated plan to the JDC for review and discussion. If any updated Commercialization Plan omits details that a NPLH representative reasonably believes is necessary for # the proper functioning of the JDC or # to verify Everest’s compliance with its obligations under this Agreement, then Everest shall take into reasonable consideration such comments and, if necessary, further update such Commercialize Plan. If the terms of the Commercialization Plan contradict, or create inconsistencies or ambiguities with, the terms of this Agreement, then the terms of this Agreement shall govern.

Commercialization Plan. At least ​ months before the scheduled date of the first BLA submission for a Licensed Product in its Territory, Kyorin will prepare and deliver to the JSC for review, input and approval, a reasonable draft written plan that summarizes the Commercialization activities (including any pre-Regulatory Approval activities in preparation for commercial launch) to be undertaken with respect to such Licensed Product in the Kyorin Territory, where such plan will include marketing and promotional activities for such Licensed Product in the Kyorin Territory aligned with the commercial positioning and the key messages approved by the JSC and will not be prepared in a manner that would adversely affect the Commercialization of the Licensed Products by or on behalf of aTyr in the United States (as updated or amended, the “Commercialization Plan”). Updates and modifications of the Commercialization Plan for a Licensed Product may be proposed by Kyorin for approval by the JSC, from time to time and no less frequently than ​, based upon, among other things, Kyorin’s Commercialization activities with respect to such Licensed Product in the Kyorin Territory.

Commercialization Plan. No later than ​ before the anticipated date of the submission of the first NDA for the Product in the Field in the Territory, Ji Xing shall submit to the JCC for review and discussion a written Commercialization plan that sets the timeline and details of all major Commercialization activities planned for the Product in the Territory (the “Commercialization Plan”). Thereafter, from time to time, but at least ​, Ji Xing shall prepare updates or amendments to the Commercialization Plan to reflect changes in such plans, including those in response to changes in the marketplace, relative success of the Product, and other relevant factors influencing such plan and activities, and submit such updated or amended plan to JCC for review and discussion before such updates and amendments become effective. Except as expressly agreed by [[Cytokinetics:Organization]] in writing or to the extent required by the applicable Regulatory Authority or to address specific operational requirements in the Territory, the Commercialization Plan shall be ​ for the Product, and the Commercialization of the Product in the Territory shall be conducted in accordance with the Commercialization Plan as amended from time to time.

Commercialization Plan. As soon as reasonably practicable, but no later than ​, Licensee shall prepare and present to the CGB a reasonably detailed plan for the Commercialization of the Product in the Licensee Territory (the “Commercialization Plan”). The Commercialization Plan will include specific information on a country-by-country basis, as Certain identified information marked with ​ has been excluded from the exhibit because it is both not material and is the type that the registrant treats as private or confidential.

Commercialization Plan. Not less than ​ prior to Commercial Launch, QIAGEN shall deliver to [[Organization A:Organization]] a draft written commercialization plan setting forth anticipated material commercialization activities to be performed with respect to the Product in such country or region in the Territory (the “Commercialization Plan”). The Commercialization Plan will be consistent with QIAGEN’s templates and processes as used by QIAGEN in its normal course of business at such time. [[Organization A:Organization]] shall promptly review such Commercialization Plan and shall, within sixty (60) days after receipt, provide comments to QIAGEN for its consideration in good faith, and QIAGEN shall not unreasonably reject any such comments. No later than ​ prior to Commercial Launch, QIAGEN shall update the Commercialization Plan, and [[Organization A:Organization]] shall have the right to review and provide comments, and QIAGEN will consider such comments with respect to such update in the manner specified in this Section 6.2. Notwithstanding anything herein to the contrary, QIAGEN shall retain final judgment over the timing of Commercial Launch in its sole discretion; provided that if QIAGEN does not satisfy the Commercial Launch requirements contained in the Exclusivity Performance Standards, the statement at the beginning of this sentence shall not impact [[Organization A:Organization]]’s right to provide the [[Organization A:Organization]] End of Exclusivity Notice pursuant to [Section 3.1.5] or the resulting consequences of such notice, as otherwise provided in this Agreement.

Commercialization Plan. At least ​ before the anticipated First Commercial Sale of the Product in the Field in a country in the Territory, MTPC will provide a strategic commercialization plan for the Products in the Field in the Territory for review and approval by the JSC (any such approved plan, the “Commercialization Plan”). The Commercialization Plan will set forth, among other things, # ​ marketing strategy that includes plans for market research, health economics, pricing and reimbursement, medical affairs and value added initiatives; # ​ communications strategy that includes plans for public relations, conferences and exhibitions and other external meetings and communications, publications and symposia, and internet activities; # a high level operating plan for the implementation of such strategies on ​ basis, including, without limitation, information related to product positioning, core messages to be communicated, and pricing strategies; # revenue targets and unit forecasts, planned for Products in the Territory and the timelines for achieving such activities; and # all other activities to be conducted by MTPC in connection with the Commercialization of Products in the Territory. During the Term, MTPC will amend the Commercialization Plan on an ongoing basis as necessary, any amendments (other than amendments required to comply with Applicable Laws or written requirements imposed by Regulatory Authorities) being subject to review and approval by the JSC, and any amendments required to comply with Applicable Laws or written requirements imposed by Regulatory Authorities being subject to report to the JSC. The Commercialization Plan must at all times contain terms that reflect the use of Commercially Reasonable Efforts to Commercialize all Products that have Regulatory Approval in the Territory and, except as otherwise expressly allocated to Viela in this Agreement, including in [Section 4.6.3] (Commercialization Cooperation), may not include any activities to be conducted by Viela, without Viela’s prior consent, which shall not be unreasonably withheld.

Commercialization. On a Licensed Compound-by-Licensed Compound basis, # [[EPIZYME:Organization]], at its sole cost, either itself or by and through its Affiliates, Sublicensees or contractors, shall have the sole right and responsibility for all Commercialization activities in connection with such Licensed Compound, any Therapeutic Product or Veterinary Product comprising such Licensed Compound and any related Diagnostic Product(s) in the Field in the [[EPIZYME:Organization]] Territory, and # EISAI, at its sole cost, either itself or by and through its Affiliates, Sublicensees or contractors, shall have the sole right and responsibility for all Commercialization activities in connection with such Licensed Compound, any Therapeutic Product or Veterinary Product comprising such Licensed Compound and any related Diagnostic Product(s) in the Field in the EISAI Territory. [[EPIZYME:Organization]] shall book all sales of Licensed Products in the [[EPIZYME:Organization]] Territory and EISAI shall book all sales of Licensed Products in the EISAI Territory.

Commercialization. creating, reviewing, and approving the Commercialization strategy and the Commercialization plan for each of the Licensed Product(s), providing guidance on implementation of such strategy and plan, and reviewing associated sales forecast;

#[[DexCom:Organization]] shall have sole discretion to decide whether to complete development of and commercialize the [[DexCom:Organization]] [[Unknown Identifier]] System and shall be under no obligation to complete such development or commercialization as a result of this Agreement.